作者单位:
Reed F. Beall, Ph.D., is an Assistant Professor at the Cummings School of Medicine and O'Brien Institute of Public Health, University of Calgary, Calgary, AB, Canada. He is also affiliated with the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. Jonathan J. Darrow, S.J.D., J.D., M.B.A., is affiliated with the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. Aaron S. Kesselheim, M.D., J.D., M.P.H., is affiliated with the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
[1]
DOI
10.1177/1073110519840499
PMID
30994060
发布时间
2020-12-14